Pharmacopolitics
(eBook)

Book Cover
Average Rating
Contributors:
Published:
[United States] : The University of North Carolina Press, 2005.
Format:
eBook
Content Description:
1 online resource (224 pages)
Lexile measure:
1450L
Status:
Description

Advocates of rapid access to medicines and critics fearful of inadequate testing both argue that globalization will supersede national medical practices and result in the easy transfer of pharmaceuticals around the world. In Pharmacopolitics, Arthur Daemmrich challenges their assumptions by comparing drug laws, clinical trials, and systems for monitoring adverse reactions in the United States and Germany, two countries with similarly advanced systems for medical research, testing, and patient care. Daemmrich proposes that divergent "therapeutic cultures--the interrelationships among governments, patients, the medical profession, and the pharmaceutical industry--underlie national differences and explain variations in pharmaceutical markets and medical care. Daemmrich carries the United States-Germany comparison from 1950 to the present through case studies of Terramycin (an antibiotic), thalidomide (a sedative), propranolol (a heart medication), interleukin-2 (a cancer therapy), and indinavir (an AIDS drug). He points to different political constructions of "the patient" in the United States and Germany to clarify important differences in government policies and in the distribution of power among key social actors. Daemmrich advises that international regulatory harmonization and globalization in medicine must retain flexibility for social and political variation between countries, even as they achieve technical standardization.

Also in This Series
More Like This
More Details
Language:
English
ISBN:
9780807863398, 0807863394
Lexile measure:
1450

Notes

Restrictions on Access
Instant title available through hoopla.
Description
Advocates of rapid access to medicines and critics fearful of inadequate testing both argue that globalization will supersede national medical practices and result in the easy transfer of pharmaceuticals around the world. In Pharmacopolitics, Arthur Daemmrich challenges their assumptions by comparing drug laws, clinical trials, and systems for monitoring adverse reactions in the United States and Germany, two countries with similarly advanced systems for medical research, testing, and patient care. Daemmrich proposes that divergent "therapeutic cultures--the interrelationships among governments, patients, the medical profession, and the pharmaceutical industry--underlie national differences and explain variations in pharmaceutical markets and medical care. Daemmrich carries the United States-Germany comparison from 1950 to the present through case studies of Terramycin (an antibiotic), thalidomide (a sedative), propranolol (a heart medication), interleukin-2 (a cancer therapy), and indinavir (an AIDS drug). He points to different political constructions of "the patient" in the United States and Germany to clarify important differences in government policies and in the distribution of power among key social actors. Daemmrich advises that international regulatory harmonization and globalization in medicine must retain flexibility for social and political variation between countries, even as they achieve technical standardization.
System Details
Mode of access: World Wide Web.
Reviews from GoodReads
Loading GoodReads Reviews.
Citations
APA Citation (style guide)

Daemmrich, A. A. (2005). Pharmacopolitics. [United States], The University of North Carolina Press.

Chicago / Turabian - Author Date Citation (style guide)

Daemmrich, Arthur A.. 2005. Pharmacopolitics. [United States], The University of North Carolina Press.

Chicago / Turabian - Humanities Citation (style guide)

Daemmrich, Arthur A., Pharmacopolitics. [United States], The University of North Carolina Press, 2005.

MLA Citation (style guide)

Daemmrich, Arthur A.. Pharmacopolitics. [United States], The University of North Carolina Press, 2005.

Note! Citation formats are based on standards as of July 2022. Citations contain only title, author, edition, publisher, and year published. Citations should be used as a guideline and should be double checked for accuracy.
Staff View
Grouped Work ID:
818f5c28-c46d-aaa7-59b0-417f3c045999
Go To GroupedWork

Hoopla Extract Information

hooplaId11718106
titlePharmacopolitics
kindEBOOK
price2.49
active1
pa0
profanity0
children0
demo0
rating
abridged0
dateLastUpdatedJan 18, 2024 06:11:41 PM

Record Information

Last File Modification TimeNov 23, 2023 12:00:43 AM
Last Grouped Work Modification TimeJan 26, 2024 03:04:47 PM

MARC Record

LEADER02847nam a22003735a 4500
001MWT11718106
003MWT
00520231028123602.1
006m     o  d        
007cr cn|||||||||
008231028s2005    xxu    eo     000 0 eng d
020 |a 9780807863398|q (electronic bk.)
020 |a 0807863394|q (electronic bk.)
02842|a MWT11718106
029 |a https://d2snwnmzyr8jue.cloudfront.net/csp_9780807863398_180.jpeg
037 |a 11718106|b Midwest Tape, LLC|n http://www.midwesttapes.com
040 |a Midwest|e rda
099 |a eBook hoopla
1001 |a Daemmrich, Arthur A.,|e author.
24510|a Pharmacopolitics|h [electronic resource] /|c Arthur A. Daemmrich.
264 1|a [United States] :|b The University of North Carolina Press,|c 2005.
264 2|b Made available through hoopla
300 |a 1 online resource (224 pages)
336 |a text|b txt|2 rdacontent
337 |a computer|b c|2 rdamedia
338 |a online resource|b cr|2 rdacarrier
347 |a text file|2 rda
506 |a Instant title available through hoopla.
520 |a Advocates of rapid access to medicines and critics fearful of inadequate testing both argue that globalization will supersede national medical practices and result in the easy transfer of pharmaceuticals around the world. In Pharmacopolitics, Arthur Daemmrich challenges their assumptions by comparing drug laws, clinical trials, and systems for monitoring adverse reactions in the United States and Germany, two countries with similarly advanced systems for medical research, testing, and patient care. Daemmrich proposes that divergent "therapeutic cultures--the interrelationships among governments, patients, the medical profession, and the pharmaceutical industry--underlie national differences and explain variations in pharmaceutical markets and medical care. Daemmrich carries the United States-Germany comparison from 1950 to the present through case studies of Terramycin (an antibiotic), thalidomide (a sedative), propranolol (a heart medication), interleukin-2 (a cancer therapy), and indinavir (an AIDS drug). He points to different political constructions of "the patient" in the United States and Germany to clarify important differences in government policies and in the distribution of power among key social actors. Daemmrich advises that international regulatory harmonization and globalization in medicine must retain flexibility for social and political variation between countries, even as they achieve technical standardization.
538 |a Mode of access: World Wide Web.
650 0|a Electronic books.
7102 |a hoopla digital.
85640|u https://www.hoopladigital.com/title/11718106?utm_source=MARC&Lid=hh4435|z Instantly available on hoopla.
85642|z Cover image|u https://d2snwnmzyr8jue.cloudfront.net/csp_9780807863398_180.jpeg